COLORECTAL TUMORS

Clinical trials for COLORECTAL TUMORS explained in plain language.

Never miss a new study

Get alerted when new COLORECTAL TUMORS trials appear

Sign up with your email to follow new studies for COLORECTAL TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1 Terminated 1

New drug combo targets hard-to-treat cancers with KRAS mutation

Disease control Ongoing

This study tests a new drug called JDQ443, given alone or with other treatments, for people with advanced solid tumors that have a specific change in the KRAS gene (G12C). The goal is to find safe doses and see if the drug can shrink tumors. About 74 adults with lung or colorecta…

Matched conditions: COLORECTAL TUMORS

Phase: PHASE1, PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated May 06, 2026 16:03 UTC

COLORECTAL TUMORS

Get alerted when new COLORECTAL TUMORS trials appear

New drug combo targets hard-to-treat cancers with KRAS mutation